Amundi
GSK icon

Amundi’s GSK GSK Stock Holding History

Amundi’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.25M Sell
61,986
-1,443
-2% -$76.3K ﹤0.01% 1077
2026
Q1 		$3.5M Sell
63,429
-2,049
-3% -$111K ﹤0.01% 1033
2025
Q4 		$3.21M Buy
+65,478
New +$3.05M ﹤0.01% 1093
2024
Q4 		– Sell
-67,884
Closed -$2.58M – 2167
2024
Q3 		$2.58M Buy
+67,884
New +$2.78M ﹤0.01% 1100
2024
Q2 		– Sell
-14,191
Closed -$557K – 1974
2024
Q1 		$557K Buy
+14,191
New +$585K ﹤0.01% 1399

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Amundi's GSK Position: Q2 2026 in Review

Amundi reduced its GSK (GSK) stake by 2.3% in Q2 2026, selling an estimated $76.3K and leaving 61,986 shares worth $3.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1077.

Amundi first reported a position in GSK in Q1 2024 and has held it in 5 quarters since. The position peaked at $3.5M in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Amundi held 61,986 shares of GSK worth $3.25M as of Q2 2026.
  • Amundi sold 1,443 GSK shares in Q2 2026, an estimated $76.3K.
  • GSK made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1077 holding.
  • Amundi first reported a position in GSK in Q1 2024 and has held it in 5 quarters since.
  • Amundi's GSK position peaked at $3.5M in Q1 2026.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.